Immunic, Inc.
IMUX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001280776
No open-market purchases or sales by Immunic, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $130.6M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Immunic, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 61 | 69 | +8 |
| Shares | 9.44M | 12.9M | +3.44M (+36.4%) |
| Value | $115.7M | $114.0M | −$1.70M (−1.5%) |
New holders (13)
Institutions that held Immunic, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Point72 Asset Management, L.P. | 625,000 | $5.53M | 0.03% |
| Sphera Funds Management Ltd. | 389,812 | $3.45M | 0.34% |
| Driehaus Capital Management LLC | 300,000 | $2.65M | 0.03% |
| First Manhattan Co | 250,000 | $2.21M | 0.01% |
| Bridgeway Capital Management, LLC | 120,800 | $1.07M | 0.02% |
| Stonepine Capital Management, LLC | 22,409 | $198.0K | 0.09% |
| Walleye Capital LLC | 19,891 | $176.0K | 0.01% |
| Boothbay Fund Management, LLC | 17,469 | $155.0K | 0.01% |
| Renaissance Technologies LLC | 16,700 | $148.0K | 0.00% |
| SG Americas Securities, LLC | 14,409 | $128.0K | 0.00% |
| Quantbot Technologies LP | 2,500 | $22.0K | 0.00% |
| Group One Trading, L.P. | 1,418 | $13.0K | 0.00% |
| Point72 Hong Kong Ltd | 123 | $1.00K | 0.00% |
Sold out (5)
Institutions that held Immunic, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Susquehanna International Group, LLP | 37,931 | $465.0K |
| Citadel Advisors LLC | 13,909 | $171.0K |
| Trexquant Investment LP | 10,674 | $131.0K |
| The PNC Financial Services Group, Inc. | 300 | $4.00K |
| O'Shaughnessy Asset Management, LLC | 24 | $0 |